(1) Various heterologous tissues incorporated in Freund’s complete adjuvant were given to rats by i.p. injection every two weeks. Kidney emulsions produced a nephrotic syndrome, and a membranous glomerulo-nephropathy. Immunization with kidneys from rabbits, guinea pigs and man produced approximately the same incidence of disease. (2) The renal disease produced by heterologous kidneys appeared immunopathogenetically identical to the lesion elicited by homologous or autologous kidneys. (3) Liver, lung, muscle, intestine and placenta were less effective in producing renal disease than was renal tissues; the disease incidences could not be shown to be significantly different from controls receiving Freund’s adjuvant alone, with the number of animals studied. (4) Kidneys obtained from nephrotic children who had died from intercurrent infections and from patients who had died of lupus with nephritis were just as antigenic in inducing this disease as were healthy human kidneys. Kidneys obtained from children who died in uremia with ‘idiopathic’ chronic nephritis yielded a significantly decreased disease incidence. (5) Kidneys obtained from rats with aminonucleoside nephrosis, experimental autoimmune nephrosis or nephrosis due to heteronephrotoxic sera all yielded decreased incidences of renal disease. This was noted regardless of the duration of the donors’ experimental disease.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.